Back to search
FDAFDA · Food and drugs·Recall number D-0461-2025

Chlorthalidone Tablets, USP, 25 mg, 50 Tablets (5x10) Unit Dose cards per carton, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-167-15

Published June 18, 2025 · Recall initiated: May 9, 2025

Summary

FDA records drug Class II recall D-0461-2025, published June 18, 2025 and initiated May 9, 2025. Recalling firm: AvKARE; Status: Ongoing; Reported quantity: 962 cartons; Lot: Lot # 47947, Exp 05/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if CHLORTHALIDONE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CHLORTHALIDONE
Manufacturer
AvKARE
Distributor
Nationwide USA
Lot
Lot # 47947, Exp 05/31/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Chlorthalidone Tablets, USP, 25 mg, 50 Tablets (5x10) Unit Dose cards per carton, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-167-15 recalled?

Yes. FDA published recall D-0461-2025 on June 18, 2025. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CHLORTHALIDONE.